Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
... Research and Development at Amgen. "These are the first
prospective Phase 3 data to demonstrate the ... women.
Vectibix is the first
fully human anti-EGFR antibody approved by the ... pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by ...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... to Abbott Molecular Inc. (AMI) in the first
quarter of 2009, Isis is reporting Ibis' ... The discontinued operations line in the first
six months of 2009 also includes the $171.8 ...
Even though Isis finished the first
six months of 2009 with a net loss from ...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... million in the second quarter of 2008. For the first
half of 2009, total operating costs and expenses ... million as compared to $115.6 million in the first
half of 2008.
"In the first
half of 2009, we made a strong commitment to ...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
... with denosumab experienced a similar time to first
skeletal-related event (SRE) (fracture, radiation ... numerically greater, the delay in the time to first
SRE associated with denosumab treatment was not ... is non-inferior to Zometa with respect to the first
on-study SRE in patients with advanced cancer ...
Project Zero Delay Accelerates Drug's Path to Clinical Trial
... -- A phase I clinical trial enrolled its first
patient only two days after U.S. Food and Drug ... a complete written protocol and enrollment of the first
patient is typically 135 days in M. D. Anderson's ... went from having a complete written protocol to first
patient in 46 days, with FDA clearance of the IND ...
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention
Paper is first
in a Series Based on Presentations from Cervical ... Gynecologic Oncologists (SGO) has published the first
in a series of four papers on a variety of ... the Forum indicates that if administered prior to first
exposure, the vaccine can prevent up to 70 ...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... in adults on Friday, July 31, 2009. It is the first
once-monthly, long-acting, injectable atypical ... maintenance treatment of schizophrenia. It is the first
once-monthly, long-acting, injectable atypical ... of relapse
following response from a first
episode of schizophrenia or
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
... Chief Medical Officer. "The data from these first
three cohorts demonstrate that we have achieved ... 15-fold more potent than Pharmasset's first
generation nucleoside polymerase inhibitor, ... Copegus(R) and is also in INFORM studies, the first
series of studies designed to assess the ...
Is Your Hair Taking a Break?
... advise that it should be addressed at the first
noticeable signs of a problem.
At the ... who specializes in hair loss, at the first
signs of a problem -- whether she notices that ... Determining the cause of the hair loss is the first
step in treating it and preventing future hair ...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
... pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by ... to the National Osteoporosis Foundation's (NOF) first
prevalence report published in 1997. This ... subsequent fractures cluster in time after first
T A C M van Geel, et al, ...
Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
... (CNS) diseases, announced today results from the first
clinical proof-of-concept study of BCI-952, a ... neurons.
"Our study results provide the first
prospective clinical validation of neurogenesis ... shaped the clinical trial protocol, directing the first
rational approach to drug development in the area ...
S.C. Medical Home Pilot for Diabetes Enrolls 1,110
... a model for South Carolina has completed its first
quarter with 1,110 patients enrolled. It is also ... treatment plan for patients.
In the first
three months, case managers hired for the project ... and better communications, and add for the first
time a focus on measurement of quality and ...
First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center
... of Wisconsin Cancer Center Riverview became the first
medical facility in the world to treat patients ... Rapids, the UW Cancer Center Riverview is the first
to treat skin cancer patients with the ... In November 2006 the Riverview center became the first
in central Wisconsin to treat patients with ...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
... and INSERM today announced the creation of the first
genetically modified mammals developed using zinc ... for the treatment of HIV/AIDS. This is the first
example of successful gene editing in mammalian ... plants and transgenic animals."
In the first
commercial application of this technique, OMT, a ...
FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
... combination of Tekturna((R)) (aliskiren), the first
and only approved direct renin inhibitor, and the ... Tekturna was approved in the US in 2007 as the first
direct renin inhibitor. In 2008, Tekturna HCT was ... or beta-blockers. TEKTURNA HCT can be used first
if your doctor thinks you are unlikely to achieve ...
New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
... non-inferiority clinical trial. It is the first
large study to directly compare the efficacy and ... These reactions occur most often during the first
18 weeks of treatment, but can occur later. ... for adults is one 200-mg tablet daily for the first
14 days, followed by one 200-mg tablet twice ...
First Potential Lupus-Specific Treatment in Sight
BENLYSTA (TM) SUCCESSFUL IN first
OF TWO PIVOTAL CLINICAL TRIALS
... largest ever to be completed for lupus and the first
Phase III (late stage) trial of a new biologic ... ultimately approve BENLYSTA, it would become the first
drug successfully developed to specifically treat ...
Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
Phase 3 Lupus Drug Trial in Decades to Show ... that we now are strongly on our way to the first
new treatment for lupus in 50 years," said LRI ... enrolled in the trial.
"This is the first
drug shown to be effective in ameliorating the ...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... met the primary endpoint in BLISS-52, the first
of two pivotal Phase 3 trials in patients with ... that BENLYSTA has the potential to become the first
new approved drug in decades for people living ... United States, Europe and other regions in the first
half of 2010."
Belimumab is an ...
Music & Medicine: Unique Collaboration Combines Performing Arts and Science
... on the modified keyboard in the past -- her first
concert on the new piano, also the first
at UNT, was a performance in 2006 of the complete ... composer Claude Debussy.
"We are the first
school to offer this [modified keyboard] to ...
First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
... today announced the successful treatment of the first
patient of its IDE feasibility trial. The case, ... Center for Minimally Invasive Surgery, marks the first
natural orifice translumenal endoscopic surgery ... and physicians."
The study, which is the first
to receive an investigational device exemption ...
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
... in complex heart valve surgery, became the first
in the world to apply this technology inside the ... Center . "Then, in March 2008, we performed the first
enlargement of the path blood follows as it exits ... for a patient undergoing valve surgery.
mitral valve reconstruction using CorMatrix ...
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
... demonstrated for both delaying the time to the first
on-study Skeletal Related Events (SREs)(fracture, ... is non-inferior to Zometa with respect to the first
on-study SRE in patients with advanced breast ... was superior to Zometa with respect to the first
on-study SRE, as well as first-and-subsequent ...
Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
... by Cervarix (R) against HPV 16 and 18. For the first
time the results show that this vaccine was ... against cervical cancer beyond what had at first
The study showed that in ... two types.
The study showed -- for the first
time for any cervical cancer vaccine -- that ...
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
... to Assess RSV Burden in Outpatient Setting During first
Year of Life; Reinforcing Commitment to Pediatric ... research with today's announcement of the first
observational prospective study designed to ... age (GA) in outpatient settings during their first
year of life.
The study also seeks to ...
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... SIMPONI moves one step closer to becoming the first
once-monthly subcutaneous anti-TNF therapy for ... Commission Decision, SIMPONI will be the first
and only once-monthly subcutaneous anti-tumor ... and symptoms of inflammatory back pain often first
present in people under the age of 35 years. On ...
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
... patients and confirm results from the first
Phase III study
PALO ALTO, Calif., and ... Confirming the positive results from the first
Phase III study, this international, ... achieved its key endpoints. As in the first
randomized, double-blind fibromyalgia study, ...
West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
... Health Institute (WWHI), one of the world's first
medical research organizations dedicated to ... with Corventis, Inc. for the Institute's first
clinical research program. Corventis is a ... ( www.westwirelesshealth.org ) is one of the first
medical research organizations in the world ...
Gene Findings Unlocking Reasons for Neuroblastoma Risk
... over the last several years, this study was the first
example of a specific CNV that predisposes people ... associated with the gene BRCA1 , which was the first
discovered familial breast cancer gene. ... Philadelphia was founded in 1855 as the nation's first
pediatric hospital. Through its long-standing ...
Alfacell Provides Shareholder Update
... communication shall mark what I hope will be the first
of many as your president.
Like many of ... agents, including platinum, are used in the first
line therapy of cancer. These genes, known as the ... Corporation
Alfacell Corporation is the first
company to advance a biopharmaceutical product ...
Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
... Florida's first
Three-Year Neuroscience Research Doctorate ... Roskamp Institute (Roskamp) today announced the first
enrollment of students in its pioneering ... director of Roskamp. "With the enrollment of our first
successful applicants, we look forward to further ...
ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
... product, with
the successful treatment of the first
patients for mild to moderate bleeding
during ... to the U.S. Food and Drug Administration in the first
2010, and conduct a combined phase II/III ... Officer, said: "The successful
treatment of the first
patients with our lead product Fibrocaps is ...
Great Basin Scientific, Inc. Raises $3.6 Million in Bridge Funding to Prepare for Launch of First Product
... the company through 2009 and the launch of its first
product, pending FDA 510(k) clearance in ... preparation for an August clinical trial for its first
test- a 50 minute diagnostic test for Methicillin ... infections (HAIs)
In addition to its first
product for MRSA testing, the company is also ...
HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
... Ltd. today announced that it has enrolled the first
of a planned 235 subjects into a Phase II dose ... living keratinocytes and fibroblasts. The first
patient was enrolled at The Center for Clinical ... to continue through the middle of 2010. The first
trial showed promising results over a four-fold ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... should consider other treatment options first
for adolescent patients.
"This Committee of ... percent of Americans(4). A substantial portion of first
psychotic breaks for schizophrenia occur in ... patients with bipolar disorder experience their first
manic episode during adolescence, with the peak ...
Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
... Side effects were observed primarily in the first
24 to 48 hours with transient pyrexia and ... commence a phase 1 clinical trial of MT203 in the first
half of 2009. Micromet's licensee Morphotek, a ... of Eisai, is also expected to initiate a first
phase 1 clinical trial with Micromet's ...
Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
... a dose of 0.06 mg/m(2) per day during the first
treatment cycle have responded according to ... commence a phase 1 clinical trial of MT203 in the first
half of 2009. Micromet's licensee Morphotek, a ... of Eisai, is also expected to initiate a first
phase 1 clinical trial with Micromet's ...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
... for Overweight and Obesity Management), the first
of two pivotal trials evaluating the safety and ...
BLOOM Trial Design
BLOOM, the first
of three lorcaserin Phase 3 trials, is a ... is a novel single agent that represents the first
in a new class of selective serotonin 2C receptor ...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... Renal and Pancreas Transplant Division, is the first
in the world to use the Intuitive Surgical's da ... stated Maureen.
Dr. Geffner performed the first
robot assisted kidney transplant in the world on ... surgeries.
Dr. Geffner is also the first
renal transplant surgeon in the region to perform ...
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
... one year."
The SONIC clinical trial is the first
of its kind to compare REMICADE, an anti-tumor ... Week meeting.
In 1998, REMICADE became the first
anti-TNF-alpha therapy approved by the FDA for ... the past decade, REMICADE has also become the first
and only anti-TNF-alpha therapy approved by the ...